JP2011501941A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011501941A5 JP2011501941A5 JP2010514184A JP2010514184A JP2011501941A5 JP 2011501941 A5 JP2011501941 A5 JP 2011501941A5 JP 2010514184 A JP2010514184 A JP 2010514184A JP 2010514184 A JP2010514184 A JP 2010514184A JP 2011501941 A5 JP2011501941 A5 JP 2011501941A5
- Authority
- JP
- Japan
- Prior art keywords
- leucine
- amine
- acid
- alpha
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95866007P | 2007-07-06 | 2007-07-06 | |
| PCT/IB2008/002490 WO2009007849A2 (en) | 2007-07-06 | 2008-07-07 | Il-23 receptor antagonists and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011501941A JP2011501941A (ja) | 2011-01-20 |
| JP2011501941A5 true JP2011501941A5 (https=) | 2011-08-25 |
Family
ID=40229172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010514184A Withdrawn JP2011501941A (ja) | 2007-07-06 | 2008-07-07 | Ｉｌ−２３レセプターのアンタゴニストおよびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20100190710A1 (https=) |
| EP (1) | EP2288621A4 (https=) |
| JP (1) | JP2011501941A (https=) |
| CN (1) | CN101990547A (https=) |
| AU (1) | AU2008273814A1 (https=) |
| CA (1) | CA2692037A1 (https=) |
| IL (1) | IL202752A0 (https=) |
| WO (1) | WO2009007849A2 (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130302343A1 (en) | 2011-01-04 | 2013-11-14 | Charité Universitätsmedizin Berlin | Modulators of il-12 and/or il-23 for the prevention or treatment of alzheimer's disease |
| CN103347532A (zh) * | 2011-02-04 | 2013-10-09 | 爱奇司治疗公司 | 口服可生物利用肽药物组合物及其方法 |
| USRE49026E1 (en) * | 2011-06-14 | 2022-04-12 | Medical Diagnostic Laboratories, Llc | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| US9605027B2 (en) * | 2011-06-14 | 2017-03-28 | Medical Diagnostic Laboratories, Llc | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| US8946150B2 (en) | 2011-06-14 | 2015-02-03 | Medical Diagnostic Laboratories, LLC. | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| CA2840405A1 (en) * | 2011-06-27 | 2013-01-03 | Galderma Research & Development | New th17 differentiation markers for acne and uses thereof |
| US20140235475A1 (en) | 2011-06-27 | 2014-08-21 | Isabelle Carlavan | Th17 differentiation markers for acne and uses thereof |
| US9273093B2 (en) | 2012-10-11 | 2016-03-01 | Protagonist Therapeutics, Inc. | α4β7 peptide dimer antagonists |
| CZ304514B6 (cs) * | 2012-11-23 | 2014-06-11 | Biotechnologický Ústav Av Čr, V.V.I. | Polypeptidy pro léčbu autoimunitních chorob založenou na blokaci receptoru pro lidský cytokin IL-23 |
| EP4091624A1 (en) | 2013-03-15 | 2022-11-23 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
| HRP20211448T1 (hr) | 2014-05-16 | 2021-12-24 | Protagonist Therapeutics, Inc. | Alfa4beta7 integrin tioeter peptidni antagonisti |
| CN107206254B (zh) | 2014-07-17 | 2021-08-24 | 领导医疗有限公司 | 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途 |
| WO2016054411A1 (en) | 2014-10-01 | 2016-04-07 | Protagonist Therapeutics, Inc. | NOVEL α4β7 PEPTIDE MONOMER AND DIMER ANTAGONISTS |
| US10301371B2 (en) | 2014-10-01 | 2019-05-28 | Protagonist Therapeutics, Inc. | Cyclic monomer and dimer peptides having integrin antagonist activity |
| US10787490B2 (en) | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| MX384213B (es) * | 2015-07-15 | 2025-03-14 | Protagonist Therapeutics Inc | Inhibidores peptidicos del receptor de interleucina 23 y su uso para tratar enfermedades inflamatorias. |
| US20190002503A1 (en) | 2015-12-30 | 2019-01-03 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| CA3017926C (en) | 2016-03-23 | 2023-10-10 | Protagonist Therapeutics, Inc. | Methods for synthesizing .alpha.4.beta.7 peptide antagonists |
| WO2018022937A1 (en) * | 2016-07-27 | 2018-02-01 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases |
| EP3681900A4 (en) | 2017-09-11 | 2021-09-08 | Protagonist Therapeutics, Inc. | OPIOID AGONIST PEPTIDES AND THEIR USES |
| CA3089868A1 (en) | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| CN108618100B (zh) * | 2018-05-10 | 2021-07-27 | 广东天企生物科技有限公司 | 一种具有鲜味和增鲜特性的四肽及其用途 |
| WO2020014646A1 (en) | 2018-07-12 | 2020-01-16 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| JP7534382B2 (ja) * | 2019-07-10 | 2024-08-14 | プロタゴニスト セラピューティクス， インコーポレイテッド | インターロイキン－２３受容体のペプチド阻害剤及び炎症性疾患を治療するためのその使用 |
| AU2021209086A1 (en) | 2020-01-15 | 2022-08-04 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| CA3167751A1 (en) | 2020-01-15 | 2021-07-22 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| JP7397239B2 (ja) | 2020-11-20 | 2023-12-12 | ヤンセン ファーマシューティカ エヌ．ベー． | インターロイキン－２３受容体のペプチド阻害剤の組成物 |
| EP4370146A4 (en) | 2021-07-14 | 2025-05-21 | Janssen Biotech, Inc. | Lipidated peptide inhibitors of the interleukin-23 receptor |
| CA3260606A1 (en) * | 2022-06-30 | 2024-01-04 | Sanofi | NEW PEPTIDES FOR USE AS SELECTIVE IL-23 RECEPTOR ANTAGONISTS |
| WO2026067838A1 (zh) * | 2024-09-30 | 2026-04-02 | 上海瀚辰星泰医药科技有限公司 | 一种多肽化合物及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000061165A1 (en) * | 1999-04-13 | 2000-10-19 | Smithkline Beecham Corporation | Conserved adhesin motif and methods of use thereof |
| AU7445900A (en) * | 1999-09-27 | 2001-04-30 | Chugai Seiyaku Kabushiki Kaisha | Novel hemopoietin receptor protein, nr12 |
| US7282204B2 (en) * | 2003-03-10 | 2007-10-16 | Schering Corporation | Uses of IL-23 agonists and antagonists; related reagents |
| US20070178520A1 (en) * | 2004-02-27 | 2007-08-02 | Barbara Wolff-Winiski | Screening assay for modulators of interaction between interleukin-12 and/or -23 with their receptors |
| WO2007004060A2 (en) * | 2005-05-05 | 2007-01-11 | Valorisation Hsj, Societe En Commandite | Cytokine receptor modulators and uses thereof |
-
2008
- 2008-07-07 JP JP2010514184A patent/JP2011501941A/ja not_active Withdrawn
- 2008-07-07 CN CN2008800236017A patent/CN101990547A/zh active Pending
- 2008-07-07 CA CA2692037A patent/CA2692037A1/en not_active Abandoned
- 2008-07-07 EP EP08807150A patent/EP2288621A4/en not_active Withdrawn
- 2008-07-07 US US12/666,028 patent/US20100190710A1/en not_active Abandoned
- 2008-07-07 AU AU2008273814A patent/AU2008273814A1/en not_active Abandoned
- 2008-07-07 WO PCT/IB2008/002490 patent/WO2009007849A2/en not_active Ceased
-
2009
- 2009-12-15 IL IL202752A patent/IL202752A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011501941A5 (https=) | ||
| US9518083B2 (en) | Gadd45beta targeting agents | |
| Botti et al. | Native chemical ligation using removable Nα-(1-phenyl-2-mercaptoethyl) auxiliaries | |
| JP2013500990A5 (https=) | ||
| JP2013155195A5 (https=) | ||
| CN101990547A (zh) | Il-23受体拮抗剂以及其应用 | |
| WO2008003943A2 (en) | Inhibition of alpha-synuclein aggregation | |
| US20140107031A1 (en) | Template-fixed peptidomimetics | |
| EP2814501A1 (en) | Melanocortin analogs having enhanced activity and transport | |
| JP2007077163A (ja) | 新規カッパレセプター選択的オピオイドペプチド | |
| Chorev et al. | Modifications of position 12 in a parathyroid hormone and parathyroid hormone-related protein: toward the design of highly potent antagonists | |
| US20110262508A1 (en) | Antimicrobial compositions, formulations and uses thereof | |
| CN1050721A (zh) | 放射性标记的抗凝血多肽 | |
| JP2020521784A5 (https=) | ||
| CN1662551A (zh) | 前列腺素e2受体亚型ep4的拮抗肽 | |
| JP2008517998A5 (https=) | ||
| JP2016505514A5 (https=) | ||
| DeGraw et al. | Stabilized analogs of thymopentin. 1. 4, 5-ketomethylene pseudopeptides | |
| Hill et al. | Enantioselection in peptide bond formation | |
| WO2007126111A1 (ja) | アミロイドβ線維化阻害ペプチド | |
| CN1039126C (zh) | 抗塔基奎宁的三环化合物,及含该化合物的药物组合物 | |
| EP1725580B1 (en) | Isosteric transformation | |
| JP7218906B2 (ja) | 血管機能の検出方法、高血圧症の進行段階を判定する方法、高血圧症の進行段階を判定するためのキット及び高血圧症の治療効果の予測方法 | |
| Samant et al. | Norcystine, a new tool for the study of the structure− activity relationship of peptides | |
| CHOREV et al. | Effects of hydrophobic substitutions at position 18 on the potency of parathyroid hormone antagonists |